Utility of gel filtration chromatography in evaluating successful resection of ectopic adrenocorticotropic hormone-producing tumor: a case report and literature review
Ectopic adrenocorticotropic hormone (ACTH) syndrome resulting from ectopically secreting tumors poses a significant clinical challenge. Accurately identifying the tumor source and achieving curative resection are pivotal for patient prognosis; however, achieving these objectives is often complicated by complex ACTH secretion patterns. High-molecular-weight ACTH, frequently secreted by ectopic ACTH-producing tumors, is distinct from the conventional 39-amino-acid ACTH (ACTH<sub>1-39</sub>) produced by the pituitary gland. We believe that the evaluation of ACTH characteristics using gel filtration chromatography (GFC) can be used to determine whether curative resection can be achieved. A patient with ectopic ACTH syndrome owing to a thymic neuroendocrine tumor was enrolled in this study. Despite a marked reduction in plasma ACTH levels post-surgery, the levels remained above the detection threshold, raising concerns regarding potential residual tumor activity. To investigate this further, GFC was employed to differentiate between ACTH<sub>1-39</sub> and high-molecular-weight ACTH in postoperative plasma samples. High-molecular-weight ACTH was predominant in the postoperative samples, whereas preoperative peripheral blood was primarily composed of ACTH<sub>1-39</sub>. These findings suggest that sustained low-level ACTH post-surgery was likely owing to a delayed clearance of high-molecular-weight ACTH rather than a residual tumor activity. This interpretation is supported by the patient's favorable postoperative course and long-term follow-up, which showed no recurrence. This case study highlights the novel potential of GFC for aiding clinical decision-making.
Authors
- Yasutaka Tsujimoto
- Hironori Bando (ORCID: https://orcid.org/0000-0002-7421-2714)
- Masaaki Yamamoto (ORCID: https://orcid.org/0000-0002-7000-8134)
- Wataru Ogawa (ORCID: https://orcid.org/0000-0002-0432-4366)
- Takefumi Doi
- Kei Yoshino (ORCID: https://orcid.org/0000-0002-8062-4379)
- Yugo Tanaka (ORCID: https://orcid.org/0000-0002-6541-1754)
- Maki Kanzawa (ORCID: https://orcid.org/0000-0003-2806-2011)
- Yoshihiko Yano (ORCID: https://orcid.org/0000-0002-5177-7480)
- Hidenori Fukuoka (ORCID: https://orcid.org/0000-0001-9255-653X)
- Mei Nakatsuji (ORCID: https://orcid.org/0009-0009-8912-8062)
- Itsuko Sato
Institutions
- Kobe University Hospital (JP)
- Kobe University (JP)
Publication Details
- Journal
- Endocrine Journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1507/endocrj.ej25-0098
- Citations
- 1
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Japan Society for the Promotion of Science